Blog | Dec. 04, 2013

Access to Prescription Drugs is a Must

Kim Cantor, Lupus Foundation of America’s Senior Director of Public Policy and Government Relations, discusses the Foundation’s Medicare for Patients RX (MAPRx) Coalition

Podcasts | Nov. 07, 2013

Human Mesenchymal Stem Cells as a Potential Therapy for Lupus

Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.

Blog | Nov. 05, 2013

Why Are Treatments That Were Developed For Malaria Now Widely Used for Lupus?

In her Expert Column, Dr. Joan T. Merrill, Medical Director, explains why antimalarial medicines are now used to treat lupus.

Research News | Oct. 30, 2013

New Research Gives Insight for Improving Future Lupus Clinical Trials

A new study that analyzed lupus treatment data from past global clinical trials suggests that when testing new drugs in combination with other background therapies, clinical trials should be designed to account for the effects that initial disease activity and background drug treatment have been shown to have on planned endpoints, like response and flare rates.

Research News | Oct. 29, 2013

Close Communications with Rheumatologist Important During Pregnancy for Women with Lupus

The outlook for positive pregnancy outcomes for women with lupus remains bright, but data obtained from a large insurance claims database highlights the need for specific education and counseling to pregnant women with lupus as well as close collaboration between the rheumatologist and the obstetrician throughout the pregnancy.

Research News | Oct. 28, 2013

Children Born to Mothers with Lupus Might be at Increased Risk of Autism

Although the overall risk is small, children born to mothers with lupus may have a higher risk of autism spectrum disorders than children born to mothers without the disease, according to the results of a study presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

General News | Oct. 25, 2013

BMJ and LFA Join Forces to Publish First Open Access Journal Dedicated to Lupus

International knowledge healthcare provider BMJ and the Lupus Foundation of America have announced that they have joined forces to publish the first open access journal dedicated to lupus. Lupus Science & Medicine™ will offer timely global access to the latest scientific advances in lupus.

General News | Oct. 24, 2013

Black Women Develop Lupus at Younger Age with More Life-Threatening Complications

There are substantial racial disparities in the burden of lupus, according to initial data from the largest and most far-reaching epidemiology study ever conducted on the disease lupus. New data from two registries, part of the National Lupus Patient Registry (NLPR), also reveal that black females disproportionately are burdened by lupus, a devastating and complicated autoimmune disease.